Kamada (KMDA) Exchange Rate Effect (2012 - 2026)
Kamada's (KMDA) quarterly Exchange Rate Effect came in at $21000.0 in Q2 2026, up 113.73% on a YoY basis from $9825.7 in Q2 2025, and up 110.4% quarter-over-quarter from -$202000.0 in Q1 2026.
Powered by 
Analysis
Kamada (KMDA) Exchange Rate Effect (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Exchange Rate Effect for 15 consecutive years, with $21000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect rose 113.73% year-over-year to $21000.0; the trailing twelve-month figure through Jun 2026 stood at -$382000.0 (down 50.99% YoY), and the FY2025 full-year result was -$273000.0, down 82.0% from the prior year.
- Exchange Rate Effect grew to $21000.0 in Q2 2026 per KMDA's latest filing, from -$202000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $482000.0 in Q4 2023 and bottomed at -$332000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged -$7888.9 across 5 years, with a median of -$12500.0 in 2024.
- The sharpest annual moves came in 2022 and 2026: Exchange Rate Effect surged 1130.77% in 2022, then slumped 349.38% in 2026.
- Over 5 years, Exchange Rate Effect stood at $112000.0 in 2022, then jumped by 330.36% to $482000.0 in 2023, then tumbled by 168.88% to -$332000.0 in 2024, then soared by 57.83% to -$140000.0 in 2025, then soared by 115.0% to $21000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $21000.0, -$202000.0, and -$140000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 315,000.00 |
| 10 | Kamada | 473.57 Mn | 403.43 Mn | 22.47 Mn | 21,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21,000.00 |
| Mar 31, 2026 | -202,000.00 |
| Dec 31, 2025 | -140,000.00 |
| Sep 30, 2025 | -61,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Sep 30, 2023 | 328,000.00 |
| Jun 30, 2023 | -248,000.00 |
| Mar 31, 2023 | -312,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | -296,000.00 |
| Jun 30, 2022 | 160,000.00 |
| Mar 31, 2022 | 236,000.00 |
| Dec 31, 2021 | -244,000.00 |
| Sep 30, 2021 | -178,000.00 |